Voronoi IPO Preview
Voronoi has developed a genotype-directed therapy that is effective for tumors caused by mutations in kinases, and has successfully conducted...
361 Views
Icure Pharm (175250 KS): High Hope for Transdermal Patch-Type Dementia Treatment Option
Icure received approval for worldās first donepezil patch for the treatment of dementia. The company estimates the patch will be over KRW 1...
648 Views
KOSPI Lockup Releases - Boryung Pharm, CJ CGV, Meritz Securities, & IBK
This post looks into the upcoming lockup releases among the KOSPI-listed stocks and examines those included in the KOSPI 200 for short-selling...
496 Views
Icure Pharm IPO Summary - Front Runner of Dementia Patch Development Race
Icure Pharm Inc (175250 KS)Ā will offer a total ofĀ 1,200,000 shares (100% new rights offering) atĀ ā©44,000 - ā©55,000 which gives a market cap of...
453 Views
More Discussions on Impacts of Celltrion's KOSPI200 Inclusion
Celltrion Inc (068270 KS)Ā said in a regulatory filing that it will have EGM at 10 AM on Aug 29 to decide whether it will move to KOSPI. Below is...
735 Views